Your browser doesn't support javascript.
loading
Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors.
Wu, Tianyu; Jiang, Xiaoqing; Zhang, Xin; Wu, Bodeng; Xu, Bin; Liu, Xiaoliu; Zheng, Lei; Wang, Yu.
Afiliação
  • Wu T; Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Jiang X; Surgical Intensive Care Unit, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Zhang X; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Wu B; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Xu B; Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Liu X; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Zheng L; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • Wang Y; Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Cancer Control ; 28: 1073274821989314, 2021.
Article em En | MEDLINE | ID: mdl-33618536

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Receptores de Fatores de Crescimento de Fibroblastos / Colangiocarcinoma / Inibidores de Proteínas Quinases Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Receptores de Fatores de Crescimento de Fibroblastos / Colangiocarcinoma / Inibidores de Proteínas Quinases Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article